News

Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development

Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development

Cartherics’ Acting Chief Scientific Officer, Dr Walid Azar recently attended the 2^nd Cell Therapy Potency Assay Summit in Boston. The Summit gathered cell therapy experts working to rationally design better potency assays to smooth the path to regulatory approval and minimise product release times with scientifically rigorous and informative potency measurements.

Potency testing has been found […]

Christine Filippis2023-06-16T11:02:21+10:00June 16th, 2023|

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21^st Advanced Summit on Life Sciences Patents in New York City. The summit provided the opportunity to engage in face-to-face discussions with leading stakeholders on the best practices to enhance global protections for patent portfolios. Now more than ever in these increasingly […]

Christine Filippis2023-05-30T15:08:10+10:00May 30th, 2023|

Cartherics to present at the 2023 BIO International Convention

Cartherics to present at the 2023 BIO International Convention

Melbourne, Australia, 24 May 2023 – Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it is presenting at the upcoming 2023 BIO International Convention June 5-8, 2023, in Boston, Massachusetts. CEO Prof. Alan Trounson will meet with senior biotech executives, business development leaders […]

Christine Filippis2023-09-06T10:30:15+10:00May 24th, 2023|

Cartherics congratulates Rasa Islam on PhD success

Cartherics congratulates Rasa Islam on PhD success

Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature.

Rasa’s research thesis, titled, Re-engineering the function of natural killer cell receptors via CRISPR/Cas9: a new approach for ‘off the shelf’ immunotherapy, investigated the generation of Natural Killer (NK) cells (immune cells) from gene-edited stem cells to provide an ‘off-the-shelf’ supply for […]

Christine Filippis2023-05-24T13:38:44+10:00May 16th, 2023|

Cartherics to present at the CIMT Annual Meeting in Germany

Cartherics to present at the CIMT Annual Meeting in Germany

Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20^th CIMT Annual Meeting in Germany.

CIMT is Europe’s largest meeting focused on cancer immunotherapy research and development. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As […]

Christine Filippis2023-05-24T13:39:14+10:00May 2nd, 2023|

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

Melbourne, Australia, 28 April 2023 – Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has granted Shunxi Holding Group Co Ltd (“Shunxi”) a licence to develop, manufacture and commercialise Cartherics’ autologous CAR-T cell product, CTH-004, for the treatment of multiple solid tumours including […]

Christine Filippis2023-04-28T13:00:59+10:00April 28th, 2023|

Cartherics’ offsite provides the opportunity to connect, engage and grow

Cartherics’ offsite provides the opportunity to connect, engage and grow

Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley just over an hour from Melbourne, the venue provided a relaxing escape for the Cartherics team to engage, connect and grow as individuals and a team.

We heard from motivational speakers, took part in a personal […]

Christine Filippis2023-04-14T15:52:01+10:00April 14th, 2023|

Cartherics proudly supports the White Shirt Campaign

Cartherics proudly supports the White Shirt Campaign

Cartherics is hosting a White Shirt Day lunch on 8^th May to help raise funds and awareness for ovarian cancer. The White Shirt Campaign officially launches on April 11^th and culminates on White Shirt Day (8 May) – World Ovarian Cancer Day.

The campaign is a 15-year partnership between the Ovarian Cancer Research Foundation (OCRF) […]

Christine Filippis2023-05-24T13:40:22+10:00April 11th, 2023|

Cartherics to present at ThymOz 2023

Cartherics to present at ThymOz 2023

Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March at Heron Island in Queensland, Australia. The conference covers a broad range of topics including T cell differentiation and function, stromal cell biology, immunotherapy and tissue regeneration.

Rachelle Duffin, PhD Candidate at Cartherics will be presenting […]

Christine Filippis2023-03-22T09:32:06+11:00March 22nd, 2023|

Cartherics to present at prestigious oncology conference in France

Cartherics to present at prestigious oncology conference in France

Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in ovarian cancer research at the European Society for Medical Oncology Targeted Anticancer Therapies Congress, ESMO TAT 2023, in Paris this March.

ESMO TAT, known as “The Home of Phase I in Oncology”, is the leading […]

Christine Filippis2023-05-24T13:41:30+10:00March 3rd, 2023|

About us

Sign up to our newsletter